|
Macrocyclics Receives National Institutes of Health SBIR Grant.
|
|
Macrocyclics recently received a Small Business Innovative Research (SBIR) grant from the National Cancer Institute. This is the second SBIR grant awarded to Macrocyclics within the last two years. With this grant Macrocyclics and its collaborators will study the benefits of copper complexes used for cancer imaging and therapy. For more information or questions, please contact Macrocyclics at info@macrocyclics.com.
|
|
|
|
|
||
 All Rights Reserved. 
|
||
